Friday 6 November 2026 Export NEOG’s income statement to Excel — free account

Neogen Corporation

NEOG Healthcare Medical Devices

Neogen Corporation’s revenue for fiscal 2026 (year ended May 2026) was $870.4 million, down 2.72% from fiscal 2025.

Revenue: +6.50%
EPS: −129.4%
Free cash flow: +135.6%
Total debt: −2.31%

Quarter to August 2026, against a year earlier

Insider buying

11.74 0.06 +0.51%

Follow NEOG

Alert me

Market cap: $2.6B
P/E: 0.0×
Fwd P/E: −93.3×
Dividend yield: —
F-score: 5/9
Altman Z: 1.11
Beneish M: −2.43
Dividend safety: n/a

Overview

Neogen Corporation (NEOG) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, Neogen Corporation (NEOG) trades at a price to free cash flow of 51.0×. Over the past ten years it has ranged from 0.0× (February 2026) to 385× (March 2026); the current reading is higher than 37% of that period. That is above the Medical Devices industry median of 28.8× and above the Healthcare sector median of 21.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/NEOG/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="Neogen Corporation price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/NEOG/metrics/price-to-free-cash-flow">Neogen Corporation (NEOG) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2026	60.6×	—
FY2025	0.0×	—
FY2024	0.0×	—
FY2023	0.0×	—
FY2022	65.3×	(26.87%)
FY2021	89.3×	46.32%
FY2020	61.1×	2.69%
FY2019	59.5×	(26.32%)
FY2018	80.7×	53.74%
FY2017	52.5×	(40.01%)

Period	Price to free cash flow	Change
Aug 2026	50.5×	(16.66%)
May 2026	60.6×	(84.26%)
Feb 2026	385×	—
Nov 2025	0.0×	—
43 more quarters	Free account

Against its own ten years

Low 0.0× High 385×

Ten-year median 60.6×

Current reading's percentile 37

Company	Price to free cash flow
BFLY Butterfly Network, Inc. compare	n/m
ESTA Establishment Labs Holdings Inc. compare	n/m
ALMR Alamar Biosciences, Inc. compare	n/m
INSP Inspire Medical Systems, Inc. compare	19.6×
UFPT UFP Technologies, Inc. compare	37.5×
NEOG Neogen Corporation	51.0×
ITGR Integer Holdings Corporation compare	53.3×
TMDX TransMedics Group, Inc. compare	53.5×
AXGN AxoGen, Inc. compare	134×
Medical Devices industry median	28.8×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

Neogen Corporation (NEOG) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on NEOG

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on NEOG

Stockrow Weekly